The article you requested is

Reply to Allergic Reactions and Sudden Death with Asenapine

J Clin Psychiatry 2012;73(5):720-721 [letter]

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

To the Editor: Thank you for your letter. The recent US Food and Drug Administration (FDA) safety announcement regarding serious hypersensitivity including anaphylaxis associated with asenapine was mentioned and referenced in the article. The details, although incomplete, are informative.

J clin Psychiatry2012; 73(4):720-721


© 2012 Physicians Postgraduate Press, Inc.​​